How we source claims

For drug facts, safety warnings, dosing schedules, approvals and contraindications, we prioritize FDA labels, DailyMed records, FDA safety communications and official manufacturer prescribing information. For coverage and pricing, we prioritize CMS, Medicare.gov, Medicaid sources, official savings pages and maintained data trackers. For nutrition and general health context, we use government health sources, clinical bodies and peer-reviewed research.

Source rules

  • Medical and regulatory claims should be checkable against a public source.
  • High-risk pages need stronger source density than general explainers.
  • Trial averages are not presented as personal predictions.
  • We do not use forum posts, social media posts, clinic marketing pages or AI summaries as sources for medical facts.
  • We do not invent medical reviewers, credentials, patient stories or expert quotes.

Drug labels and prescribing information

TopicPrimary sourceUsed for
WegovyDailyMed Wegovy labelIndications, dosing, warnings, contraindications and adverse reactions
ZepboundDailyMed Zepbound labelIndications, dosing, sleep apnea approval context, warnings and adverse reactions
OzempicDailyMed Ozempic label searchType 2 diabetes use, cardiovascular risk language, warnings and adverse reactions
MounjaroDailyMed Mounjaro label searchType 2 diabetes use, tirzepatide dosing, warnings and adverse reactions
RybelsusDailyMed Rybelsus label searchOral semaglutide use, administration instructions and warnings
SaxendaDailyMed Saxenda labelOlder liraglutide weight-management label, adolescent use and adverse reactions

FDA safety and pharmacy sources

Coverage, pricing and access sources

Nutrition and general health sources

Search and AI-search sources

Medical disclaimer: This page explains our source standards. It is not medical advice. GLP-1 medications are prescription drugs with risks and contraindications. Talk to a qualified clinician about your own situation.